Get 20M+ Full-Text Papers For Less Than $1.50/day. Start a 14-Day Trial for You or Your Team.

Learn More →

Administration of the TrkB receptor agonist 7,8‐dihydroxyflavone prevents traumatic stress‐induced spatial memory deficits and changes in synaptic plasticity

Administration of the TrkB receptor agonist 7,8‐dihydroxyflavone prevents traumatic... Post‐traumatic stress disorder (PTSD) occurs after exposure to traumatic situations and it is characterized by cognitive deficits that include impaired explicit memory. The neurobiological bases of such PTSD‐associated memory alterations are yet to be elucidated and no satisfactory treatment for them exists. To address this issue, we first studied whether a single exposure of young adult rats (60 days) to immobilization on boards (IMO), a putative model of PTSD, produces long‐term behavioral effects (2–8 days) similar to those found in PTSD patients. Subsequently, we investigated whether the administration of the TrkB agonist 7,8‐dihydroxyflavone (DHF) 8 h after stress (therapeutic window) ameliorated the PTSD‐like effect of IMO and the associated changes in synaptic plasticity. A single IMO exposure induced a spatial memory impairment similar to that found in other animal models of PTSD or in PTSD patients. IMO also increased spine density and long‐term potentiation (LTP) in the CA3‐CA1 pathway. Significantly, DHF reverted both spatial memory impairment and the increase in LTP, while it produced no effect in the controls. These data provide novel insights into the possible neurobiological substrate for explicit memory impairment in PTSD patients, supporting the idea that the activation of the BDNF/TrkB pathway fulfils a protective role after severe stress. Administration of DHF in the aftermath of a traumatic experience might be relevant to prevent its long‐term consequences. © 2016 Wiley Periodicals, Inc. http://www.deepdyve.com/assets/images/DeepDyve-Logo-lg.png Hippocampus Wiley

Administration of the TrkB receptor agonist 7,8‐dihydroxyflavone prevents traumatic stress‐induced spatial memory deficits and changes in synaptic plasticity

Loading next page...
 
/lp/wiley/administration-of-the-trkb-receptor-agonist-7-8-dihydroxyflavone-Eo7RaoAS6V

References (51)

Publisher
Wiley
Copyright
© 2016 Wiley Periodicals, Inc.
ISSN
1050-9631
eISSN
1098-1063
DOI
10.1002/hipo.22599
pmid
27068341
Publisher site
See Article on Publisher Site

Abstract

Post‐traumatic stress disorder (PTSD) occurs after exposure to traumatic situations and it is characterized by cognitive deficits that include impaired explicit memory. The neurobiological bases of such PTSD‐associated memory alterations are yet to be elucidated and no satisfactory treatment for them exists. To address this issue, we first studied whether a single exposure of young adult rats (60 days) to immobilization on boards (IMO), a putative model of PTSD, produces long‐term behavioral effects (2–8 days) similar to those found in PTSD patients. Subsequently, we investigated whether the administration of the TrkB agonist 7,8‐dihydroxyflavone (DHF) 8 h after stress (therapeutic window) ameliorated the PTSD‐like effect of IMO and the associated changes in synaptic plasticity. A single IMO exposure induced a spatial memory impairment similar to that found in other animal models of PTSD or in PTSD patients. IMO also increased spine density and long‐term potentiation (LTP) in the CA3‐CA1 pathway. Significantly, DHF reverted both spatial memory impairment and the increase in LTP, while it produced no effect in the controls. These data provide novel insights into the possible neurobiological substrate for explicit memory impairment in PTSD patients, supporting the idea that the activation of the BDNF/TrkB pathway fulfils a protective role after severe stress. Administration of DHF in the aftermath of a traumatic experience might be relevant to prevent its long‐term consequences. © 2016 Wiley Periodicals, Inc.

Journal

HippocampusWiley

Published: Sep 1, 2016

Keywords: ; ; ; ; ;

There are no references for this article.